Introduction to the recommendations of the EASL clinical practice guidelines for genetic cholestatic liver diseases
10.3760/cma.j.cn501113-20240820-00377
- VernacularTitle:《欧洲肝病学会遗传性胆汁淤积性肝病的临床实践指南》推荐意见简介
- Author:
Wei HOU
1
;
Sujun ZHENG
1
Author Information
1. 首都医科大学附属北京佑安医院肝病中心，北京 100069
- Publication Type:Journal Article
- Keywords:
Hereditary cholestasis;
Genetic cholestatic liver diseases;
Diagnosis;
Therapeutic;
Guidance;
European Association for the Study of the Liver
- From:
Chinese Journal of Hepatology
2025;33(6):545-550
- CountryChina
- Language:Chinese
-
Abstract:
Genetic cholestatic liver disease is a type of disease caused by several different gene mutations, with cholestasis as the main manifestation, and is usually rare. Although these diseases differ in pathophysiology, clinical manifestations, and prognosis, they all possess the common feature of cholestasis. To this end, the European Association for the Study of the Liver published the EASL Clinical Practice Guidelines for Genetic Cholestatic Liver Disease in 2024, which provide a general approach to the management of cholestatic pruritus, detailed information on the diagnosis and treatment method of certain hereditary cholestatic liver diseases, and put forward recommendations on diagnosis and treatment with the aim to assist hepatologists (pediatric and adult) in implementing the latest diagnostic and management strategies.
